Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload

被引:173
作者
Kuster, GM
Kotlyar, E
Rude, MK
Siwik, DA
Liao, RL
Colucci, WS
Sam, F
机构
[1] Boston Univ, Sch Med, Dept Med, Myocardial Biol Unit, Boston, MA 02118 USA
[2] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA
[3] Boston Univ, Med Ctr, Cardiovasc Med Sect, Boston, MA 02118 USA
关键词
aldosterone; stress; oxidative; inflammation;
D O I
10.1161/01.CIR.0000153800.09920.40
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - Although aldosterone, acting via mineralocorticoid receptors, causes left ventricular (LV) hypertrophy in experimental models of high-aldosterone hypertension, little is known about the role of aldosterone or mineralocorticoid receptors in mediating adverse remodeling in response to chronic pressure overload. Methods and Results - We used the mineralocorticoid receptor - selective antagonist eplerenone (EPL) to test the role of mineralocorticoid receptors in mediating the transition from hypertrophy to failure in mice with chronic pressure overload caused by ascending aortic constriction (AAC). One week after AAC, mice were randomized to regular chow or chow containing EPL ( 200 mg/kg per day) for an additional 7 weeks. EPL had no significant effect on systolic blood pressure after AAC. Eight weeks after AAC, EPL treatment improved survival (94% versus 65%), attenuated the increases in LV end-diastolic (3.4 +/- 0.1 versus 3.7 +/- 0.1 mm) and end-systolic (2.0 +/- 0.1 versus 2.5 +/- 0.2 mm) dimensions, and ameliorated the decrease in fractional shortening ( 42 +/- 2% versus 34 +/- 4%). EPL also decreased myocardial fibrosis, myocyte apoptosis, and the ratio of matrix metalloproteinase-2/tissue inhibitor of matrix metalloproteinase-2. These beneficial effects of EPL were associated with less myocardial oxidative stress, as assessed by 3-nitrotyrosine staining, reduced expression of the adhesion molecule intercellular adhesion molecule-1, and reduced infiltration by macrophages. Conclusions - Mineralocorticoid receptors play an important role in mediating the transition from LV hypertrophy to failure with chronic pressure overload. The effects of mineralocorticoid receptor stimulation are associated with alterations in the interstitial matrix and myocyte apoptosis and may be mediated, at least in part, by oxidative stress and inflammation.
引用
收藏
页码:420 / 427
页数:8
相关论文
共 47 条
[21]   Cardiac-specific overexpression of GLUT1 prevents the development of heart failure attributable to pressure overload in mice [J].
Liao, RL ;
Jain, M ;
Cui, L ;
D'Agostino, J ;
Aiello, F ;
Luptak, I ;
Ngoy, S ;
Mortensen, RM ;
Tian, R .
CIRCULATION, 2002, 106 (16) :2125-2131
[22]   Traumatic brain injury regulates adrenocorticosteroid receptor mRNA levels in rat hippocampus [J].
McCullers, DL ;
Sullivan, PG ;
Scheff, SW ;
Herman, JP .
BRAIN RESEARCH, 2002, 947 (01) :41-49
[23]  
Mizuno Y, 2001, CIRCULATION, V103, P72
[24]   RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN RABBITS WITH CONGESTIVE HEART-FAILURE PRODUCED BY AORTIC CONSTRICTION [J].
MORRIS, BJ ;
DAVIS, JO ;
ZATZMAN, ML ;
WILLIAMS, GM .
CIRCULATION RESEARCH, 1977, 40 (03) :275-282
[25]   Simvastatin prevents load-induced protein tyrosine nitration in overloaded hearts [J].
Nadruz, W ;
Lagosta, VJ ;
Moreno, H ;
Coelho, OR ;
Franchini, KG .
HYPERTENSION, 2004, 43 (05) :1060-1066
[26]   Differential activation of matrix metalloproteinases in heart failure with and without ventricular dilatation [J].
Nishikawa, N ;
Yamamoto, K ;
Sakata, Y ;
Mano, T ;
Yoshida, J ;
Miwa, T ;
Takeda, H ;
Hori, M ;
Masuyama, T .
CARDIOVASCULAR RESEARCH, 2003, 57 (03) :766-774
[27]   Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction [J].
Pitt, B ;
Remme, W ;
Zannad, F ;
Neaton, J ;
Martinez, F ;
Roniker, B ;
Bittman, R ;
Hurley, S ;
Kleiman, J ;
Gatlin, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (14) :1309-1321
[28]   The effect of spironolactone on morbidity and mortality in patients with severe heart failure [J].
Pitt, B ;
Zannad, F ;
Remme, WJ ;
Cody, R ;
Castaigne, A ;
Perez, A ;
Palensky, J ;
Wittes, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (10) :709-717
[29]   Mineralocorticoid receptor blockade: new insights into the mechanism of action in patients with cardiovascular disease [J].
Pitt, B ;
Stier, CT ;
Rajagopalan, S .
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2003, 4 (03) :164-168
[30]   ETA-receptor blockade prevents matrix metalloproteinase activation late postmyocardial infarction in the rat [J].
Podesser, BK ;
Siwik, DA ;
Eberli, FR ;
Sam, F ;
Ngoy, S ;
Lambert, J ;
Ngo, K ;
Apstein, CS ;
Colucci, WS .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2001, 280 (03) :H984-H991